IMRIS Inc.
DelistedCIK 1489161fmd_1PHFZCEXE50W50YMF72ZKZ2T6MManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2014, 11 periods
Latest annual · FY2014
Millions- Total revenues
- 29
- Gross profit
- 10
- Operating income
- (23)
- Net income
- (30)
- Free cash flow
- 8
Latest quarter · Q4 FY2014
Millions- Total revenues
- 10
- Gross profit
- 4
- Operating income
- (4)
- Net income
- (7)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- -17.7%
IMRIS Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | $28.9 million | $46 million | -37.3% | 20-F 2015-04-01 · proof |
| Gross profit | $9.9 million | $15.7 million | -36.6% | 20-F 2015-04-01 · proof |
| Operating income | -$23.1 million | -$39.3 million | 20-F 2015-04-01 · proof | |
| Net income | -$30.4 million | -$42 million | 20-F 2015-04-01 · proof | |
| Cash from operating activities | $10.9 million | $40.6 million | -73.2% | 20-F 2015-04-01 · proof |
| Free cash flow | $8.4 million | $31.4 million | -73.3% | 20-F 2015-04-01 · proof |
| Total assets | $65.5 million | $85.6 million | -23.5% | 20-F 2015-04-01 · proof |
| Total liabilities | $53.7 million | $50.5 million | +6.2% | 20-F 2015-04-01 · proof |
| Cash and cash equivalents | $5 million | $6.4 million | -21.6% | 20-F 2015-04-01 · proof |
- What was IMRIS Inc.'s revenue in fiscal 2014?
- IMRIS Inc. reported revenue of $28.9 million for fiscal 2014 (the year ended Dec 31, 2014), against $46 million the year before (-37.3%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What was IMRIS Inc.'s gross profit in fiscal 2014?
- IMRIS Inc. reported gross profit of $9.9 million for fiscal 2014 (the year ended Dec 31, 2014), against $15.7 million the year before (-36.6%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What was IMRIS Inc.'s operating income in fiscal 2014?
- IMRIS Inc. reported operating income of -$23.1 million for fiscal 2014 (the year ended Dec 31, 2014), against -$39.3 million the year before. Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What was IMRIS Inc.'s net income in fiscal 2014?
- IMRIS Inc. reported net income of -$30.4 million for fiscal 2014 (the year ended Dec 31, 2014), against -$42 million the year before. Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What was IMRIS Inc.'s cash from operating activities in fiscal 2014?
- IMRIS Inc. reported cash from operating activities of $10.9 million for fiscal 2014 (the year ended Dec 31, 2014), against $40.6 million the year before (-73.2%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What was IMRIS Inc.'s free cash flow in fiscal 2014?
- IMRIS Inc. reported free cash flow of $8.4 million for fiscal 2014 (the year ended Dec 31, 2014), against $31.4 million the year before (-73.3%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What are IMRIS Inc.'s total assets?
- As of Dec 31, 2014, IMRIS Inc. reported total assets of $65.5 million, against $85.6 million a year earlier (-23.5%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What are IMRIS Inc.'s total liabilities?
- As of Dec 31, 2014, IMRIS Inc. reported total liabilities of $53.7 million, against $50.5 million a year earlier (+6.2%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
- What are IMRIS Inc.'s cash and cash equivalents?
- As of Dec 31, 2014, IMRIS Inc. reported cash and cash equivalents of $5 million, against $6.4 million a year earlier (-21.6%). Source: the 20-F filed with the SEC on Apr 1, 2015. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1489161&period_type=annual&limit=5"Information only, not investment advice.